A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial

Clinical trial NCT02618902 · COMPLETED

Trial details

NCT number: NCT02618902
Sponsor: University Hospital, Antwerp
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2017-05-30
Primary completion: 2022-02-03
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.